Design Therapeutics, Inc. (DSGN)

Design Therapeutics, Inc. (DSGN) is a healthcare company (biotechnology) based in the United States. The share price is $9.76, down 1.61% on the day, which values the company at $624.99M. Price as of 17 Nov 2026, 18:16 UTC, from Yahoo Finance.

Key facts

Share price
$9.76−1.61% today
Market value
$624.99M
200-week average
$6.4751% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Design Therapeutics, Inc. in more detail

DSGN trades at -6.3× next year's expected earnings. It sits 51% above its 200-week average of $6.47.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold DSGN, including Julian and Felix Baker (0.2% of the portfolio).

Superinvestors holding DSGN

1 of the investors tracked here report a position in their latest 13F filing.

Design Therapeutics, Inc. (DSGN): questions and answers

What is Design Therapeutics, Inc.'s market cap?

Design Therapeutics, Inc. is valued at $624.99M at a share price of $9.76.

Is DSGN above its 200-week moving average?

Yes. DSGN is 50.8% above its 200-week average of $6.47. Long-term investors watch that line because strong companies rarely trade below it for long.

Does DSGN pay a dividend?

Design Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own DSGN?

In their latest quarterly filings, Julian and Felix Baker (0.2% of the portfolio) hold DSGN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Design Therapeutics, Inc. (DSGN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DSGN

Underlying data: Yahoo Finance; company filings with the SEC.